Approval · Notice of Compliance 10136 · 2009
CEFPROZIL: Notice of Compliance 10136
Issued April 8, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10136
- Date
- April 8, 2009
- Company
- Pro Doc LimiteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Antibiotic
- Canadian reference product
- CEFZIL (Bristol-Myers Squibb Canada)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEFPROZIL | 02324172 | — |
| CEFPROZIL | 02324180 | Cancelled Post Market |
Medicinal ingredients
- CEFPROZIL MONOHYDRATE 250 MG per TAB
- CEFPROZIL MONOHYDRATE 500 MG per TAB